Unknown

Dataset Information

0

Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis.


ABSTRACT: Checkpoint with Forkhead-associated and Ring finger domains (CHFR) is a G2/M checkpoint and tumor-suppressor gene. Recent publications showed the correlation of CHFR promoter methylation with clinicopathological significance of non-small cell lung cancer (NSCLC), however, the results remain inconsistent. The aim of this study is to investigate the Clinicopathological significance of CHFR promoter methylation in NSCLC with a meta-analysis. A total of nine studies were included in the meta-analysis that 816 patients were involved. Our data indicated that the frequency of CHFR promoter methylation was higher in NSCLC than in normal lung tissue, Odd Ratios (OR) was 9.92 with 95% corresponding confidence interval (CI) 2.17-45.23, p = 0.003. Further subgroup analysis revealed that CHFR promoter was more frequently methylated in squamous cell carcinoma (SCC) than in adenocarcinoma (ADC), OR was 4.46 with 95% CI 1.65-12.05, p = 0.003, suggesting the mechanism of SCC pathogenesis is different from ADC. Notably, CHFR promoter methylation was correlated with smoking behavior in NSCLC. In conclusion, CHFR could be a biomarker for diagnosis of NSCLC, and a promising drug target for development of gene therapy in SCC. CHFR promoter methylation is potentially associated with poor overall survival, additional studies need to be carried out for confirmation in future.

SUBMITTER: Wang C 

PROVIDER: S-EPMC5752556 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinicopathological significance of <i>CHFR</i> methylation in non-small cell lung cancer: a systematic review and meta-analysis.

Wang Chen C   Ma Wenxia W   Wei Rong R   Zhang Xiaoqin X   Shen Ningning N   Shang Lifang L   E Li L   Wang Ying Y   Gao Lifang L   Li Xin X   Wang Bin B   Zhang Yaping Y   Du Aiping A  

Oncotarget 20171023 65


Checkpoint with Forkhead-associated and Ring finger domains (<i>CHFR</i>) is a G2/M checkpoint and tumor-suppressor gene. Recent publications showed the correlation of <i>CHFR</i> promoter methylation with clinicopathological significance of non-small cell lung cancer (NSCLC), however, the results remain inconsistent. The aim of this study is to investigate the Clinicopathological significance of <i>CHFR</i> promoter methylation in NSCLC with a meta-analysis. A total of nine studies were include  ...[more]

Similar Datasets

| S-EPMC5839373 | biostudies-literature
| S-EPMC4726317 | biostudies-other
| S-EPMC7665804 | biostudies-literature
| S-EPMC5780517 | biostudies-other
| S-EPMC4461130 | biostudies-literature
| S-EPMC7450343 | biostudies-literature
| S-EPMC4069179 | biostudies-literature
| S-EPMC8270596 | biostudies-literature
| S-EPMC4567004 | biostudies-literature